The anti‐hepatic fibrosis effects of dihydrotanshinone I are mediated by disrupting the yes‐associated protein and transcriptional enhancer factor D2 complex and stimulating autophagy-Reference-Cited by-同舟云学术

The anti‐hepatic fibrosis effects of dihydrotanshinone I are mediated by disrupting the yes‐associated protein and transcriptional enhancer factor D2 complex and stimulating autophagy

Published:2017-04-06 Issue:10 Volume:174 Page:1147-1160
ISSN:0007-1188
Container-title:British Journal of Pharmacology
language:en
Short-container-title:British Journal of Pharmacology

Author:

Ge Maoxu¹,Liu Hong¹,Zhang Yixuan¹,Li Naren¹,Zhao Shuangshuang¹,Zhao Wuli¹,Zhen Yongzhan²,Yu Jianzhong³,He Hongwei¹,Shao Rong‐guang¹

Affiliation:

1. Key Laboratory of Biotechnology of Antibiotics Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College Beijing China

2. Hebei Key Laboratory for Chronic Diseases, School of Basic Medical Sciences North China University of Science and Technology Tangshan China

3. Department of Anatomy and Physiology Kansas State University College of Veterinary Medicine Manhattan KS 66506 USA

Funder

the Beijing Nature Scientific Foundation

the National Mega-project for Innovative Drugs of China

CAMS Innovation Fund for Medical Sciences;CIFMS;

the National Nature Scientific Foundation of China

Publisher

Wiley

Subject

Pharmacology

Link